Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease

Heeschen, C, Lehmann, R, Honold, J, Assmus, B, Aicher, A, Walter, DH, Martin, H, Zeiher, AM and Dimmeler, S, 2004. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation, 109 (13), pp. 1615-1622. ISSN 0009-7322

Preview

Text 197522_1980 Aicher Publisher.pdf Download (358kB) | Preview

Abstract

Background— Cell therapy with bone marrow–derived stem/progenitor cells is a novel option for improving neovascularization and cardiac function in ischemic heart disease. Circulating endothelial progenitor cells in patients with coronary heart disease are impaired with respect to number and functional activity. However, whether this impairment also extends to bone marrow–derived mononuclear cells (BM-MNCs) in patients with chronic ischemic cardiomyopathy (ICMP) is unclear

Item Type:	Journal article
Publication Title:	Circulation
Creators:	Heeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D.H., Martin, H., Zeiher, A.M. and Dimmeler, S.
Publisher:	American Heart Association
Place of Publication:	Dallas, Texas, USA
Date:	2004
Volume:	109
Number:	13
ISSN:	0009-7322
Identifiers:	Number Type 10.1161/01.CIR.0000124476.32871.E3 DOI
Rights:	Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited
Divisions:	Schools > School of Science and Technology
Record created by:	EPrints Services
Date Added:	09 Oct 2015 10:09
Last Modified:	08 Feb 2024 11:18
URI:	https://irep.ntu.ac.uk/id/eprint/8581

Actions (login required)

Edit View

Statistics

Views

Downloads